ServiceXS To Use Illumina Platform for European Melanoma Genotyping Study | GenomeWeb
NEW YORK (GenomeWeb News) – ServiceXS, a genomics and proteomics services firm based in Leiden, the Netherlands, will perform a large-scale genome-wide association study for the European Union’s Melanoma Genetics Consortium, the company said Friday.
ServiceXS said it will use Ilumina’s Infinium multiplex technology to genotype 300,000 tag SNPs in 1,800 subjects for the GenoMEL study.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.